(1).jpg)
Telemedicine platform developer Maple raised $14.5 million in its most recent investment round.
Maple’s platform allows patients to access some 400 healthcare practitioners using any supported device, saving them from having to visit a doctor in person for a consultation. The platform even allows users to engage with healthcare practitioners from specific areas of expertise, from dermatology to psychotherapy, and lactation consulting.
The latest investment round for Maple was led by Munich-based Acton Capital. SE Health, a provider of home healthcare services, also participated in the round. Following closure of the round, SE Health and Maple have agreed to a strategic partnership, integrating the latter’s telemedicine solutions to the former’s services.
BetaKit reported that the funding will be used to expand Maple’s hospital and home care divisions. The funding will also be used to further develop the product.
“We’ve always made the conscious decision to put Canada first in every service we develop,” said Maple co-founder and CEO Dr. Brett Belchetz.
Belchetz underlined in a statement that the funding comes after a record year in which Maple’s revenue grew six times. The company also raised an undisclosed funding and investment amount from RBC earlier this year, the chief executive outlined.
Maple was one of the start-ups chosen to participate in Aviva Canada’s InsurTech Growth Program last year.
Also last year, the company took part in Market Security Analysis (MSA) Research’s InsurTech North event. The start-up was nominated to participate by OneEleven, a scale-up innovation hub that previously collaborated with Aviva Canada over the InsurTech Growth Program.
Maple has partnered with employers, insurers, governments, and hospitals to implement its platform. The start-up’s corporate partners include Morneau Shepell, ENCON Group, and GlaxoSmithKline – which has utilized Maple in benefits programs for its employees.
